LIST OF BINDING INTERFACES for query 'TYROSINE-PROTEIN KINASE BTK' in category 'PROTEIN NAME'

(Click on the 'Details' column to view details on interfaces and similar patterns of amino acids)
Click on the 'View' column to view patterns on the structural viewer)

PDB	Ligand	Drug	Indication	Macromolecule/ Organism	Pfam	Binding_Interfaces (View)	Details
3k54	1N1	Dasatinib (DB01254)	Dasatinib is a tyrosine kinase inhibitor used for the treatment of lymphoblastic or chronic myeloid leukemia with resistance or intolerance to prior therapy.	TYROSINE-PROTEIN KINASE BTK (Homo sapiens)	PK_Tyr_Ser-Thr	3K54_A_1N1A1	Details
5p9i	1E8	Ibrutinib (DB09053)	Ibrutinib is an antineoplastic agent used to treat chronic lymphocytic leukemia, mantle cell lymphoma, and Waldenstrom's Macroglobulinemia.	TYROSINE-PROTEIN KINASE BTK (Homo sapiens)	PK_Tyr_Ser-Thr	5P9I_A_1E8A701	Details
6j6m	BA0	Zanubrutinib (DB15035)	Zanubrutinib is a kinase inhibitor used to treat mantle cell lymphoma, a type of B-cell non-Hodgkin lymphoma, in adults who previously received therapy.	TYROSINE-PROTEIN KINASE BTK (Homo sapiens)	PK_Tyr_Ser-Thr	6J6M_A_BA0A701	Details
PDB	Ligand	Drug	Indication	Macromolecule/ Organism	Pfam	Binding_Interfaces (View)	Details

[["3k54","1N1","Dasatinib (DB01254)","Homo sapiens","TYROSINE-PROTEIN KINASE BTK","PK_Tyr_Ser-Thr"],["5p9i","1E8","Ibrutinib (DB09053)","Homo sapiens","TYROSINE-PROTEIN KINASE BTK","PK_Tyr_Ser-Thr"],["6j6m","BA0","Zanubrutinib (DB15035)","Homo sapiens","TYROSINE-PROTEIN KINASE BTK","PK_Tyr_Ser-Thr"]]